Kayne Anderson BDC, Inc.
KBDC NYSE Financials FY2021–FY2025
Last close · Oct 23, 2026
$12.76
0.1%What Kayne Anderson BDC, Inc. does
No business description yet.
- Legal name
- Kayne Anderson BDC, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 2, 2026
- Accession · CIK
- 0001213900-26-022392
0001747172
Revenue and margins
Kayne Anderson BDC, Inc. had — of revenue in fiscal 2025.
Net income and earnings per share
From fiscal 2021 to 2025, diluted EPS grew 15.5% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Kayne Anderson BDC, Inc. returned $171M to shareholders in fiscal 2025. The diluted share count rose 10.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Kayne Anderson BDC, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $5.7M | $18.4M | $46.9M | $71.1M | $18.0M |
| Interest coverage | — | −1.7x | −1.5x | −1.4x | −1.5x |
| Total assets | $586M | $1.2B | $1.4B | $2.1B | $2.3B |
| Total liabilities | $274M | $602M | $741M | $896M | $1.2B |
| Shareholders' equity | $312M | $592M | $683M | $1.2B | $1.1B |
| Net debt (− = net cash) | — | — | — | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✕ | ✕ | ✕ | ✕ | ✕ |
| Return on assets rose | — | ✓ | ✓ | ✓ | ✕ |
| Cash from operations exceeds net income | ✕ | ✕ | ✕ | ✕ | ✕ |
| Debt fell relative to assets | — | — | — | — | — |
| Current ratio rose | — | — | — | — | — |
| Share count didn't rise | — | ✕ | ✕ | ✕ | ✕ |
| Gross margin rose | — | — | — | — | — |
| Revenue rose relative to assets | — | — | — | — | — |
| F-score | — / 3 | — / 5 | — / 5 | — / 5 | — / 5 |
| Accruals ratio | 99.1% | 66.0% | 14.3% | 38.6% | 8.8% |
| Altman Z'' | — | — | — | — | — |
5 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Operating income | — | −$34.7M | −$76.2M | −$83.8M | −$118M |
| Interest expense | $4.5M | $20.3M | $52.3M | $61.5M | $76.4M |
| Income tax | — | — | — | $0.7M | $1.7M |
| Net income | $22.3M | $45.8M | $77.1M | $132M | $93.7M |
| Diluted EPS | $0.94 | $1.48 | $2.16 | $2.03 | $1.67 |
| Diluted shares | 0.01B | 0.03B | 0.04B | 0.06B | 0.07B |
| Cash flow | |||||
| Cash from operations | −$559M | −$542M | −$110M | −$545M | −$98.7M |
| Share buybacks | — | — | — | $1.5M | $48.0M |
| Dividends paid | — | — | $70.0M | $102M | $123M |
| Dividends and buybacks | — | — | $70.0M | $103M | $171M |
| Balance sheet | |||||
| Cash and short-term investments | $5.7M | $18.4M | $46.9M | $71.1M | $18.0M |
| Total assets | $586M | $1.2B | $1.4B | $2.1B | $2.3B |
| Total liabilities | $274M | $602M | $741M | $896M | $1.2B |
| Shareholders' equity | $312M | $592M | $683M | $1.2B | $1.1B |
| Returns | |||||
| Return on equity | 7.1% | 10.1% | 12.1% | 14.1% | 8.2% |
| Return on assets | 3.8% | 5.1% | 5.9% | 7.5% | 4.3% |
| Return on tangible equity | 7.1% | 7.7% | 11.3% | 11.1% | 8.4% |
| Growth | |||||
| Net income growth | — | 105.3% | 68.4% | 71.2% | −29.0% |
| EPS growth | — | 57.4% | 45.9% | −6.0% | −17.7% |
| Share count change | — | 153.6% | 44.4% | 62.5% | 10.2% |
| Financial health | |||||
| Interest coverage | — | −1.7x | −1.5x | −1.4x | −1.5x |
| Quality scores | |||||
| Accruals ratio | 99.1% | 66.0% | 14.3% | 38.6% | 8.8% |
Source: SEC EDGAR XBRL filings (CIK 0001747172). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
